SCHEMBL14616857

SCHEMBL14616857

CCCOCC(COCC(COCC(COCC(COCC(COCC(COCCC)OCCC)OCCC)OCCC)OCCC)OCCC)OCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 1/20 0.45
LPAR1 Q92633 9/20 0.43
LPAR3 Q9UBY5 9/20 0.43
LPAR2 Q9HBW0 6/20 0.43
USP2 O75604 1/20 0.39
HTT P42858 1/20 0.38
DNM1 Q05193 1/20 0.37
TLR2 O60603 2/20 0.33
PRKD3 O94806 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33
PRKCH P24723 1/20 0.33
PRKCI P41743 1/20 0.33
PRKCE Q02156 1/20 0.33
PRKCQ Q04759 1/20 0.33
PRKCZ Q05513 1/20 0.33
PRKCD Q05655 1/20 0.33
PRKD1 Q15139 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12410368 1.00 HSD17B10 (0.48) HSD17B10TDP1LPAR1LPAR3LPAR2
SCHEMBL14616848 1.00 HSD17B10 (0.48) HSD17B10TDP1LPAR1LPAR3LPAR2
SCHEMBL209403 0.97 HSD17B10 (0.50) HSD17B10TDP1LPAR1LPAR3LPAR2
SCHEMBL14616846 0.93 HSD17B10 (0.43) HSD17B10TDP1LPAR1LPAR3LPAR2
SCHEMBL14616845 0.93 HSD17B10 (0.43) HSD17B10TDP1LPAR1LPAR3LPAR2
SCHEMBL16473876 0.90 HSD17B10 (0.44) HSD17B10TDP1LPAR1LPAR3LPAR2
Ether SCHEMBL11844631 0.90 HSD17B10 (0.44) HSD17B10TDP1LPAR1LPAR3LPAR2
SCHEMBL14616851 0.89 HSD17B10 (0.40) HSD17B10TDP1LPAR1LPAR3LPAR2
SCHEMBL23408864 0.87 HSD17B10 (0.46) HSD17B10TDP1LPAR1LPAR3LPAR2
SCHEMBL14870365 0.87 LPAR1 (0.38) HSD17B10TDP1LPAR1LPAR3LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS ENZON PHARMACEUTICALS, INC. (US) 2013-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS VEGFA, MKI67, PCNA HSD17B10 4271/4885TDP1 1879/4885LPAR1 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.